March 31, 2020
Article
A poster presented at CROI 2020 examined rates of TB screening among people living with HIV in PEPFAR supported countries.
March 25, 2020
Patients facing HIV stigma may encounter difficulties with retention in care.
March 19, 2020
George Hanna, MD, vice president and therapeutic head of infectious diseases at Merck Laboratories, discusses data from CROI 2020 on islatravir.
March 16, 2020
An antibody gene delivered by a harmless virus produced anti-HIV antibodies for a sustained period.
March 13, 2020
Higher HIV incidence is associated with higher viral burden, according to results from the PopART trial presented at CROI 2020.
A poster on antiviral PEP safety and tolerability was presented at CROI 2020.
March 12, 2020
A new study examining the reasons for suboptimal PrEP use among MSM was presented at CROI 2020.
Data from clinical and preclinical studies on the use of the investigational HIV-1 capsid inhibitor GS-6207 were presented via 3 posters at CROI 2020.
Unaddressed mental health challenges among youth living with HIV complicate antiretroviral therapy (ART) adherence, leading to high mortality and lower rates of viral suppression among this population.
March 11, 2020
Contagion® spoke to Onyema Ogbuagu, MD, who presented the week 96 results from the DISCOVER study evaluating F/TAF and F/TDF.
